Company intelligence / Profile preview

IMCD

Ownership: Private
Employees: ~4700
Development stage: Commercial

Overview

IMCD operates as a global leader in the distribution and formulation of specialty chemicals and ingredients for life sciences, including pharmaceuticals, nutraceuticals, food, personal care, cosmetics, home care, water treatment and more. The company has expanded its presence through acquisitions such as YCAM in South Korea and Daoqin in China to strengthen its life science portfolio. In pharma specifically, it focuses on APIs, excipients, nutraceuticals/active nutraceutical ingredients (ANI), with an emerging presence in biopharma.

Modalities: Small moleculeBiologicNutraceuticalsExcipientsActive pharmaceutical ingredients (API)Functional nutrition ingredientsCosmetic/personal care ingredients
Industry: Chemicals & Materials

Partnerships

BASFFuji ChemicalInnophosLonzaWackerProcelys

Beyond the preview

Go deeper on IMCD.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on IMCD.

Explore the full profile